Ratio of notch receptors is critical for response to notch inhibition by a gamma-secretase inhibitor in triple negative breast cancer cells

被引：0
|
作者：
Zlobin, A. [1 ]
Kuprys-Olsauskas, R. [1 ]
Shah, D. [1 ]
Osipo, C. [1 ]
机构：
[1] Loyola Univ Chicago, Maywood, IL USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P6-05-25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-05-25
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Preclinical profile of a potent gamma-secretase inhibitor targeting Notch signaling with in vivo efficacy and pharmacodynamic properties
    Luistro, Leopoldo
    Smith, Melissa
    Packman, Kathryn
    He, Wei
    Vilenchik, Maria
    Carvajal, Daisy
    Roberts, John
    Cai, James
    Berkofsky-Fessler, Windy
    Hilton, Holly
    Wei, Xin
    Linn, Michael
    Flohr, Alexander
    Jacob-Roetne, Roland
    Jacobsen, Helmut
    Heimbrook, David
    Boylan, John
    CANCER RESEARCH, 2009, 69
  • [32] THE EFFECT OF NOTCH BLOCKADE WITH DBZ, A GAMMA-SECRETASE INHIBITOR, ON THE IN VITRO AND IN VIVO GROWTH OF A NEUROBLASTOMA CELL LINE
    Freed, Jennifer
    Hernandez, Sonia
    Kandel, Jessica J.
    Yamashiro, Darrell
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 742 - 742
  • [33] Transient gamma-secretase inhibition accelerates and enhances fracture repair likely via Notch signaling modulation
    Wang, Cuicui
    Shen, Jie
    Yukata, Kiminori
    Inzana, Jason A.
    O'Keefe, Regis J.
    Awad, Hani A.
    Hilton, Matthew J.
    BONE, 2015, 73 : 77 - 89
  • [34] Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
    Sparling, David P.
    Yu, Junjie
    Kim, KyeongJin
    Zhu, Changyu
    Brachs, Sebastian
    Birkenfeld, Andreas L.
    Pajvani, Utpal B.
    MOLECULAR METABOLISM, 2016, 5 (02): : 113 - 121
  • [35] Repurposing sulindac sulfide as a notch inhibitor to target cancer stem-like cells in triple negative breast cancer
    Hossain, F.
    Ucar, D.
    Majumder, S.
    Xu, K.
    Ran, Y.
    Minter, L.
    Xi, Y.
    Burow, M.
    Golde, T.
    Osborne, B.
    Miele, L.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Gamma-secretase inhibitor as novel therapy for antiestrogen resistant breast cancer.
    Liu, H.
    Cheng, D.
    Miele, L.
    Lupu, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S169 - S169
  • [37] Effects of a gamma-secretase inhibitor of notch signalling on transforming growth factor β1-induced urethral fibrosis
    Huang, Shanlong
    Fu, Delai
    Wan, Ziyan
    Li, Min
    Li, Hecheng
    Chong, Tie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (18) : 8796 - 8808
  • [38] 1-Methoxyphaseollidin: Novel gamma secretase inhibitor targeting notch-1 signaling in breast cancer stem cells
    Kolluru, Venkatesh
    Pal, Deeksha
    Baby, Becca
    Alatassi, Houda
    Sharma, Arun Kumar
    Ankem, Murali
    Damodaran, Chendil
    CANCER RESEARCH, 2017, 77
  • [39] Clinically relevant plasma protein binding of R04929097, a gamma-secretase inhibitor targeting notch signaling
    Wu, Jianmei
    LoRusso, Patricia
    Li, Jing
    CANCER RESEARCH, 2011, 71
  • [40] Cimigenoside functions as a novel γ-secretase inhibitor and inhibits the proliferation or metastasis of human breast cancer cells by γ-secretase/Notch axis
    Jia, Hui
    Liu, Mingyue
    Wang, Xinying
    Jiang, Qiyu
    Wang, Shu
    Santhanam, Ramesh Kumar
    Lv, Chongning
    Zhao, Qingchun
    Lu, Jincai
    PHARMACOLOGICAL RESEARCH, 2021, 169
12345